MA26293A1 - Nouvelle maladie bacterienne des poulets, pasteurella trehalosi et/ou mannheimia haemolytica, la bacterie, le vaccin et la methode d'immunisation des poulets contre cette maladie . - Google Patents

Nouvelle maladie bacterienne des poulets, pasteurella trehalosi et/ou mannheimia haemolytica, la bacterie, le vaccin et la methode d'immunisation des poulets contre cette maladie .

Info

Publication number
MA26293A1
MA26293A1 MA27700A MA27700A MA26293A1 MA 26293 A1 MA26293 A1 MA 26293A1 MA 27700 A MA27700 A MA 27700A MA 27700 A MA27700 A MA 27700A MA 26293 A1 MA26293 A1 MA 26293A1
Authority
MA
Morocco
Prior art keywords
disease
vaccine
bacteria
methods
mannheimia haemolytica
Prior art date
Application number
MA27700A
Other languages
English (en)
Inventor
Maria Elena Vazquez
Raul Campogarrido
Carlos Gonzales-Hernandez
Vaithianathan Sivanandan
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of MA26293A1 publication Critical patent/MA26293A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
MA27700A 2001-10-26 2004-05-25 Nouvelle maladie bacterienne des poulets, pasteurella trehalosi et/ou mannheimia haemolytica, la bacterie, le vaccin et la methode d'immunisation des poulets contre cette maladie . MA26293A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10152307A DE10152307A1 (de) 2001-10-26 2001-10-26 Neue bakterielle Geflügelkrankheit

Publications (1)

Publication Number Publication Date
MA26293A1 true MA26293A1 (fr) 2004-09-01

Family

ID=7703460

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27700A MA26293A1 (fr) 2001-10-26 2004-05-25 Nouvelle maladie bacterienne des poulets, pasteurella trehalosi et/ou mannheimia haemolytica, la bacterie, le vaccin et la methode d'immunisation des poulets contre cette maladie .

Country Status (31)

Country Link
US (3) US7794735B2 (fr)
EP (2) EP1942181A1 (fr)
JP (2) JP4447319B2 (fr)
KR (2) KR101024887B1 (fr)
CN (1) CN100471945C (fr)
AR (3) AR037020A1 (fr)
AT (1) ATE391767T1 (fr)
AU (1) AU2002363173B2 (fr)
BR (1) BR0213538A (fr)
CA (1) CA2462652A1 (fr)
CO (1) CO5580796A2 (fr)
CY (1) CY1108178T1 (fr)
DE (2) DE10152307A1 (fr)
DK (1) DK1442114T3 (fr)
EC (1) ECSP045083A (fr)
ES (1) ES2304466T3 (fr)
HR (1) HRP20040366B1 (fr)
HU (1) HU228692B1 (fr)
IL (1) IL161223A0 (fr)
MA (1) MA26293A1 (fr)
MX (1) MXPA04003941A (fr)
MY (1) MY138203A (fr)
NO (1) NO333635B1 (fr)
NZ (1) NZ532805A (fr)
PL (1) PL206589B1 (fr)
PT (1) PT1442114E (fr)
RU (4) RU2334792C2 (fr)
SI (1) SI1442114T1 (fr)
UA (2) UA96948C2 (fr)
WO (1) WO2003037367A2 (fr)
ZA (1) ZA200402499B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10152307A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Vetmed Neue bakterielle Geflügelkrankheit
CN102781954A (zh) * 2009-10-09 2012-11-14 哥本哈根大学 来自鸡卡氏杆菌的细胞溶解性rtx-毒素
CN102380092A (zh) * 2011-11-22 2012-03-21 青岛易邦生物工程有限公司 一种鸡传染性鼻炎灭活疫苗
CN102406936A (zh) * 2011-11-22 2012-04-11 青岛易邦生物工程有限公司 一种鸡传染性鼻炎灭活疫苗佐剂
AU2014234452B2 (en) 2013-03-18 2018-02-22 Intervet International B.V. Vaccine to protect a ruminant against pneumonia caused by Mannheimia haemolytica
RU2563885C1 (ru) * 2014-06-03 2015-09-27 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Способ определения антител к бактериальным антигенам
CN104491856A (zh) * 2014-12-07 2015-04-08 青岛易邦生物工程有限公司 一种禽肺病毒病灭活疫苗的生产方法
CN108728558A (zh) * 2018-05-31 2018-11-02 广西壮族自治区兽医研究所 一种快速检测溶血性曼氏杆菌的pcr扩增引物及其应用
CN111621450B (zh) * 2020-07-10 2022-07-05 青岛易邦生物工程有限公司 一种鸭源鸡杆菌及其应用
CN120060520B (zh) * 2025-04-03 2026-02-03 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 一种检测海藻糖比伯斯坦杆菌的引物对和试剂盒

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5855894A (en) * 1992-03-30 1999-01-05 Pfizer Inc. Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
RU2051970C1 (ru) * 1992-06-24 1996-01-10 Северо-Кавказский зональный научно-исследовательский ветеринарный институт Способ выявления бактерий pasteurella multocida при пастереллезном процессе у птиц
ZA937652B (en) 1992-10-14 1994-05-04 Akzo Nv New bacterium causing poultry disease and vaccine derived thereof
US5587305A (en) * 1993-12-06 1996-12-24 The United States Of America As Represented By The Department Of Agriculture Pasteurella haemolytica transformants
RU2103355C1 (ru) * 1995-11-23 1998-01-27 Государственное Федеральное предприятие Государственный научный центр прикладной микробиологии Способ получения аттенуированных иммуногенных штаммов pasteurella multocida
FR2760640B1 (fr) * 1997-03-17 1999-05-28 Vetoquinol Sa Utilisation d'une souche de pasteurella haemolytica serotype a6 pour la preparation d'un vaccin contre la pasteurellose bovine due a pasteurella haemolytica
CN1245058A (zh) * 1998-08-18 2000-02-23 曾泳铭 一种兽用抗病毒组合物
US7304151B2 (en) * 1999-12-17 2007-12-04 University Of Guelph Modified leukotoxin gene and protein
US7521060B2 (en) 2001-10-26 2009-04-21 Boehringer Ingelheim Vetmedica S.A. De C.V. Pathogen for bacterial poultry disease
DE10152307A1 (de) 2001-10-26 2003-05-08 Boehringer Ingelheim Vetmed Neue bakterielle Geflügelkrankheit

Also Published As

Publication number Publication date
US20090181055A1 (en) 2009-07-16
ZA200402499B (en) 2005-06-08
NZ532805A (en) 2008-04-30
US20100104594A1 (en) 2010-04-29
MXPA04003941A (es) 2004-11-29
JP4447319B2 (ja) 2010-04-07
DE60226057T2 (de) 2009-05-14
PT1442114E (pt) 2008-05-20
WO2003037367A2 (fr) 2003-05-08
PL369963A1 (en) 2005-05-02
UA96948C2 (ru) 2011-12-26
EP1942181A1 (fr) 2008-07-09
DE60226057D1 (de) 2008-05-21
HRP20040366A2 (en) 2005-04-30
UA89607C2 (ru) 2010-02-25
NO333635B1 (no) 2013-07-29
NO20041675L (no) 2004-04-23
AU2002363173B2 (en) 2007-09-20
CN100471945C (zh) 2009-03-25
KR20090083941A (ko) 2009-08-04
RU2007129099A (ru) 2009-02-10
CO5580796A2 (es) 2005-11-30
JP5087604B2 (ja) 2012-12-05
RU2007148219A (ru) 2009-07-10
ES2304466T3 (es) 2008-10-16
AR037020A1 (es) 2004-10-20
MY138203A (en) 2009-05-29
AR067732A2 (es) 2009-10-21
CA2462652A1 (fr) 2003-05-08
RU2456343C2 (ru) 2012-07-20
RU2430967C2 (ru) 2011-10-10
HUP0402098A3 (en) 2005-07-28
US20110212132A1 (en) 2011-09-01
JP2010051324A (ja) 2010-03-11
CN1575334A (zh) 2005-02-02
RU2004116134A (ru) 2005-05-10
CY1108178T1 (el) 2014-02-12
HU228692B1 (en) 2013-05-28
ATE391767T1 (de) 2008-04-15
ECSP045083A (es) 2004-08-27
EP1442114B1 (fr) 2008-04-09
BR0213538A (pt) 2004-10-19
DE10152307A1 (de) 2003-05-08
PL206589B1 (pl) 2010-08-31
RU2334792C2 (ru) 2008-09-27
HUP0402098A2 (hu) 2005-02-28
US7964197B2 (en) 2011-06-21
SI1442114T1 (sl) 2008-08-31
AR073482A2 (es) 2010-11-10
RU2481393C2 (ru) 2013-05-10
DK1442114T3 (da) 2008-06-09
JP2005511032A (ja) 2005-04-28
US7794735B2 (en) 2010-09-14
WO2003037367A3 (fr) 2003-10-09
HRP20040366B1 (hr) 2012-05-31
HK1073862A1 (zh) 2005-10-21
KR100954175B1 (ko) 2010-04-20
RU2008136404A (ru) 2010-03-20
EP1442114A2 (fr) 2004-08-04
KR101024887B1 (ko) 2011-03-31
KR20050039688A (ko) 2005-04-29
IL161223A0 (en) 2004-09-27

Similar Documents

Publication Publication Date Title
CY1108178T1 (el) Βακτηριο που προκαλει νοσο των πουλερικων και εμβολιο προερχομενο εξ' αυτου
ATE440861T1 (de) Immunisierung gegen chlamydia pneumoniae
MX9710412A (es) Antigeno omp26 de haemophilus influenzae.
EP1791561A4 (fr) Calicivirus felin hemorragique, vaccin contre le calicivirus et methode de prevention de l'infection ou de la maladie a calicivirus
MY125202A (en) Vaccine
MXPA01011047A (es) Secuencias genomicas de neisseria y metodos para su uso.
WO2002021141A3 (fr) Procedes et compositions relatifs a des maladies associees a l'amyloide
EP1144998A3 (fr) Sequences genomiques de neisseria et procedes d'utilisation
PT1741443E (pt) Combinação de vacinas para a meningite b/c
US20070049546A1 (en) Substituted, non-coding nucleic acid molecule for therapeutic and prophylactic stimulation of the immune system in humans and higher animals
EP1450605A4 (fr) Composition et methode permettant de modifier la masse maigre et les proprietes osseuses d'un sujet
DE60324299D1 (de) Zusammensetzungen gegen coccidiosis bei hühnern
PL344851A1 (en) Bacterium of salmonella type and vaccine containing that bacterium for protecting animals against salmonellosis and method of obtaining such vaccine
WO2001078787A3 (fr) Vaccin conjugue anti-sepsie
EA200100700A1 (ru) Гены и белки и их применение
WO2003083083A3 (fr) Procedes d'utilisation d'un ligand flt3 dans des protocoles d'immunisation
WO2001022994A3 (fr) Vaccin
WO2004103401A3 (fr) Composition de vaccin aviaire destinee a la protection de volailles contre des maladies et des infections causees par e. coli; et les salmonelles
AU772882B2 (en) Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease
WO2004074491A3 (fr) Expression dans des plantes d'anticorps contre l'escherichia coli entero-toxigene
FR2807764B1 (fr) Mutants de bacteries lactiques surproducteurs d'exopolysaccharides
EA200100701A1 (ru) Белки наружной поверхности, их гены и их применение
FR2652266A1 (fr) Vaccin protecteur contre l'hemophilose porcine.
DE602004031127D1 (de) Attenuierte bakterielle lebendvakzine
Yokogawa et al. In ovo vaccination of Marek's disease type I virus